Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of XERS Xeris Pharmaceuticals | -24.1% in 12m

Compare XERS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Xeris Pharmaceuticals with its related Sector/Index XLV

Compare Xeris Pharmaceuticals with its related Sector/Index XLV

Performance Duell XERS vs XLV

TimeFrame XERS XLV
1 Day -1.12% -0.01%
1 Week -13.3% -1.83%
1 Month -17.4% -4.41%
3 Months -29.0% -0.32%
6 Months -0.56% 7.47%
12 Months -24.1% 5.36%
YTD -22.3% 0.11%
Rel. Perf. 1m -1.40
Rel. Perf. 3m -1.09
Rel. Perf. 6m -0.76
Rel. Perf. 12m -2.85

Is Xeris Pharmaceuticals a good stock to buy?

Probably not. Based on ValueRay Fundamental Analyses, Xeris Pharmaceuticals (NASDAQ:XERS) is currently (April 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -4.99 and therefor a somewhat negative outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XERS as of April 2024 is 1.36. This means that XERS is currently overvalued and has a potential downside of -22.73%.

Is XERS a buy, sell or hold?

  • Strong Buy: 4
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
Xeris Pharmaceuticals has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy XERS.
Values above 0%: XERS is performing better - Values below 0%: XERS is underperforming

Compare XERS with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -9.73% -14.77% -17.50% -46.48%
US NASDAQ 100 QQQ -8.37% -14.15% -17.53% -57.82%
US Dow Jones Industrial 30 DIA -11.56% -14.82% -13.86% -37.49%
German DAX 40 DBXD -12.56% -16.79% -18.59% -35.86%
UK FTSE 100 ISFU -12.52% -17.67% -8.93% -28.02%
Shanghai Shenzhen CSI 300 CSI 300 -15.14% -15.72% -0.70% -6.74%
Hongkong Hang Seng HSI -7.31% -8.64% 11.00% 2.77%
Japan Nikkei 225 EXX7 -9.74% -12.27% -15.33% -42.54%
India NIFTY 50 INDA -10.85% -18.10% -16.05% -52.25%
Brasil Bovespa EWZ -7.93% -11.49% -4.11% -34.27%

XERS Xeris Pharmaceuticals vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -10.47% -16.94% -20.73% -62.56%
Consumer Discretionary XLY -8.43% -13.04% -9.30% -40.61%
Consumer Staples XLP -12.75% -15.06% -10.55% -24.12%
Energy XLE -9.33% -20.33% -4.42% -36.33%
Financial XLF -11.40% -14.83% -21.79% -45.66%
Health Care XLV -11.47% -12.96% -8.03% -29.50%
Industrial XLI -10.45% -16.39% -21.49% -45.52%
Materials XLB -10.56% -15.59% -17.23% -35.30%
Real Estate XLRE -8.28% -9.55% -8.31% -23.19%
Technology XLK -7.45% -12.66% -18.22% -56.57%
Utilities XLU -12.91% -19.28% -11.29% -20.87%
Aerospace & Defense XAR -10.68% -14.27% -13.71% -37.31%
Biotech XBI -4.75% -7.18% -22.47% -26.80%
Homebuilder XHB -9.39% -13.58% -39.13% -71.39%
Retail XRT -9.39% -11.10% -18.10% -38.84%

XERS Xeris Pharmaceuticals vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -9.90% -18.40% 0.77% -35.52%
Natural Gas UNG -10.40% -11.37% 49.23% 26.81%
Gold GLD -13.55% -27.52% -22.38% -42.44%
Silver SLV -12.72% -30.25% -24.00% -35.85%
Copper CPER -17.46% -25.21% -25.58% -35.04%

Returns of XERS vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -12.21% -13.56% -7.76% -12.54%
iShares High Yield Corp. Bond HYG -12.55% -16.05% -9.11% -31.30%
Does Xeris Pharmaceuticals outperform its market, is XERS a Sector Leader?
No, over the last 12 months Xeris Pharmaceuticals (XERS) made -24.14%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 5.36%.
Over the last 3 months XERS made -29.03%, while XLV made -0.32%.
Period XERS XLV S&P 500
1 Month -17.37% -4.41% -2.60%
3 Months -29.03% -0.32% 5.16%
12 Months -24.14% 5.36% 22.34%